Cipla | CIPLA - Operating Expenses

Stock Price
1,299.00
Daily Change
-15.70 -1.19%
Monthly
-3.34%
Yearly
-12.97%
Q1 Forecast
1,289.06

Cipla reported INR60.98B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Arca Biopharma USD 25.09M 5.23M Mar/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
Bio Path USD 3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD 3.09M 100K Mar/2025
Capricor Therapeutics USD 24.98M 6.15M Mar/2025
Cara Therapeutics USD 4.96M 2.38M Mar/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Immunic USD 25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD 10.7M 1.54M Jun/2023
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Nektar Therapeutics USD 85.09M 109.3M Sep/2025
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
TherapeuticsMD USD 1.41M 50K Jun/2024
UPL INR 106.63B 780M Dec/2025